Actavis seeking FDA approval to market generic version of Gilead drug

Dublin-based company wants to sell a version of a pulmonary arterial hypertension treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.